MBC 101
These episodes provide information to help you understand more about what an MBC diagnosis entails, from the basic science of metastases to options for treatment.
Featured
These episodes provide information to help you understand more about what an MBC diagnosis entails, from the basic science of metastases to options for treatment.
The DESTINY-Breast04 trial at ASCO 2022 introduced many people to the term “HER2-low.” But how do you know if you’re HER2-low? In this episode, with the help a breast pathologist and a clinical oncologist we dive into this subtype and what it means to us.
What does it mean when our cancer shows progression? And how do we know when that happens? The Our MBC Life team gets the lowdown from Dr. Stephanie L. Graff.
On 10/12/21 Lianne Kraemer, an MBC patient advocate living with brain mets , and SHARE hosted two brilliant young clinicians from Moffitt in a discussion on management of breast cancer brain metastases. Today we are bringing you this webinar with our additional commentary. We will let you in on a little secret. This episode is a glimpse into how we envision the next season’s Road to a Cure. It will include more content with an educational angle for the newly diagnosed or those who are ready to take a deeper dive with us into the basics. We call it MBC101.
We know the challenges of trials and the barriers to recruitment as outlined in part 1. Now in Part 2 we explore solutions with patient advocates and medical professionals who are working to find ways forward. Clinical Trials from a Patient Perspective Part II. Let’s solve this.
What’s it like to try and find a trial as a patient? What are the challenges and hurdles that have to be overcome? How do we get to a better place? In this episode we hear the perspective of patients and then go to the experts to get some answers. Part 1 of a 2 part series on Clinical Trials.
Anne Loeser and Dr. Aditya Bardia join the podcast to talk about the importance of getting The Right Dose.
Did you know that not ALL breast cancer can be detected by a lump? We are joined by Laurie Hutcheson of the Lobular Breast Cancer Alliance and researchers Steffi Oesterreich, PhD and Adrian Lee, PhD why ILC is difficult to research and what looks promising for the future.
Kate Keith and Michael Singer share their experiences with male breast cancer. Kate shares personal stories about her husband Ryan who died earlier this year from metastatic breast cancer.
A conversation with Dr. Nancy Lin, Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute.
Being diagnosed with MBC can feel like you’ve been dropped into a dangerous and alien landscape, one whose inhabitants speak a new and confusing language. Numb and bewildered, you face a mountain of medical decisions—each with seemingly high stakes. The last in Our MBC Life’s 3-part series for people newly diagnosed with MBC, this episode's interview with Dr. Rebecca Shatsky, interspersed with experienced-patient voices, sheds light on cancer types, tests, and treatment—and empowers listeners to navigate this challenging new terrain with understanding, knowledge, and confidence.